Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued stocks in the Chemicals industry for Friday, May 23, 2025. Let’s take a ...

The pharmaceutical industry, which is well known for its well-resourced lobbying campaigns, has a lesser-known tactic for influencing policy: bankrolling ostensibly independent nonprofit ...

Piramal Pharma Ltd has more than tripled investor wealth since 2023-24. With the Mumbai-based drug development and manufacturing company turning around its business recently, its stock has ...

In this article, we are going to take a look at where ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stands against other Friday’s top performers. The stock market finished the trading week in the ...

Indian pharma stocks fell 1.6% on Monday (May 12, 2025), bucking broader market gains, after U.S. President Donald Trump said he would cut drug prices by 30%–80% to match other wealthy nations.

President Donald Trump took on Big Pharma Monday with an executive order that will reduce the prices for prescriptions. The president said the U.S. “will no longer tolerate profiteering and ...

For the second year in a row, the pharmaceutical industry has dipped further out of favor with patient groups around the world. The industry’s reputation surged during the COVID-19 pandemic ...

Aurobindo Pharma subsidiary Eugia Pharma Specialities has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market Dasatinib Tablets in different ...

China's Hengrui Pharma is looking to raise up to $1.27 billion in its Hong Kong IPO. And more. 1. Pfizer partner RemeGen says HER2 ADC prolongs life in newly diagnosed bladder cancer RemeGen’s ...

LONDON, April 25 (Reuters) - A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% if passed on ...

Apellis Pharmaceuticals is a Buy due to the significant FCF potential of SYFOVRE® and EMPAVELI®, with SYFOVRE® projected to exceed $1bn in annual sales by 2028. SYFOVRE® has shown efficacy in ...

A Cambridge-based pharmaceutical company is laying off close to a hundred employees. Ono Pharma USA, a subsidiary of the Japanese pharmaceutical company of the same name, filed with the state last ...